SLS SELLAS Life Sciences Group, Inc
$7.15▼ -6.90%
Unknown
Other
Last sync: just now
Syncing
Key Metrics & Fundamentals
Market Cap
$1.41B
P/E Ratio
–
Div Yield
–%
52W Range
1.39 - 9.51
% vs 50 MA
26.92%
% vs 200 MA
107.73%
RSI-14
52.3
MACD Histogram
-0.1600
Beta (1Y vs SPY)
1.92
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Volume (M)
Financial Overview - Income Statement
Quarterly
N/A
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
Avg +0.68 · 46 posts
DiscussionSLS, NBIS or SNXX for this coming week
r/wallstreetbets · Jun 1, 2026
The post notes 'a lot of positivity online for SLS'.
positive
+0.60
DiscussionSLS, NBIS or SNXX for this coming week
r/investing · Jun 1, 2026
The post expresses 'a lot of positivity online for SLS'.
positive
+0.60
TradeDiscussionNewsSpace is the place, man
r/wallstreetbets · May 22, 2026
The author expresses strong optimism about SLS based on trial results and a potential buyout.
positive
+0.70
NewsDiscussionTradeAll in on cancer $SLS
r/wallstreetbets · May 20, 2026
The author expresses strong bullish sentiment regarding SLS's trial results and positions are ‘full port’.
very_positive
+0.90
DiscussionTradeDDSell some Intel to take a larger position in SLS? I’m OKAY with the greed, but I’m not sure my logic is sound.
r/stocks · May 16, 2026
The author expresses belief in the company and highlights a potential price target ($7) contingent on a positive trial.
positive
+0.60
Page 1 of 10 (46 total)
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not Financial Advice.
All data, scores, charts, and analysis on this site are provided for informational and educational purposes only
and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
Always consult a qualified financial advisor before making any investment decisions.
See our Legal Notice for full details.